Definitive Contract 75D30120C08021
Award Date
4/27/20
Potential Completion Date
4/26/21
Potential Value
$728K
Federal Agency
CDC Pittsburgh
Awardee
Quest Diagnostics Incorporated
Ultimate Awardee
Quest Diagnostics Incorporated
NAICS Category
621511 - Medical Laboratories
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with an ID of 75D30124P19524, was issued by the Centers for Disease Control and Prevention (CDC) Pittsburgh office to Quest Diagnostics Incorporated, a leading provider of clinical laboratory services. The $93,600.00 firm fixed-price contract is for the delivery of de-identified nasopharyngeal specimens to support the CDC's public health research initiatives. The contract has an ultimate completion date of August 13, 2026 and was awarded on August 14, 2024 without...
The Centers for Disease Control and Prevention (CDC) awarded a $16,500 purchase order to Quest Diagnostics Incorporated for deidentified Quest serum aliquots. Quest Diagnostics will deliver the aliquots to the CDC location in Halethorpe, Maryland by September 28, 2023 under the firm fixed price contract that began on September 1, 2023. As one of the largest clinical laboratories and medical testing companies in the United States, Quest Diagnostics will utilize its extensive experience and...
The Centers for Disease Control and Prevention (CDC) awarded a $8,587,890.00 firm fixed price definitive contract to Quest Diagnostics Nichols Institute, doing business as Quest Diagnostics, for genomic sequencing services. The contract supports the CDC's disease prevention and health promotion efforts through genomic surveillance of viruses like COVID-19. This contract does not have a set-aside designation. Quest Diagnostics Nichols Institute, a subsidiary of the parent company Quest...
This contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Quest Diagnostics Incorporated, a for-profit diagnostic information services provider, for data submission services. The contract is a definitive, firm fixed-price contract with a potential value of $722,500.00. The purpose is to obtain laboratory test order and test result data, including longitudinal patient identifiers but without personally identifiable information, to...
The Centers for Disease Control and Prevention (CDC) awarded a $14 million firm fixed price delivery order contract to Quest Diagnostics Incorporated for surge serology testing services. Under the contract, Quest Diagnostics will provide COVID-19 antibody testing from its laboratory located in Secaucus, New Jersey to support the CDC's pandemic response efforts. The period of performance is from July 30, 2020 through November 19, 2020. No set aside designation or subcontractors were identified....
The Centers for Disease Control and Prevention awarded a firm-fixed price contract valued at $1,676,070.04 to Quest Diagnostics Clinical Laboratories, Inc. to meet requirements established in a January 2020 solicitation. The solicitation sought longitudinal laboratory test order and result data for hosting in CDC's Data Hub to support analyses of public health trends related to reportable diseases and exposures over time. Only Quest could fulfill this requirement due to its market share and...
Quest Diagnostics Incorporated has been awarded a firm fixed price, definitive contract valued at twenty-one million, seven hundred ninety-five thousand, twenty-six dollars by the Centers for Disease Control and Prevention to provide MASS-C serology services. Performance will take place in Secaucus, New Jersey with a completion date of December 11, 2023. No set-aside designation was used for this solicitation. As a leading provider of diagnostic information services, Quest Diagnostics will...
This is a $24,691,200 firm-fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Quest Diagnostics Incorporated for serology testing services. The contract has a period of performance through March 5, 2022 and was awarded on November 13, 2020 without any set-aside designation. Quest Diagnostics, a for-profit diagnostic information services provider, has previously supported federal agencies such as the Department of Justice's Bureau of Prisons, the...
This is a $4,470,182.84 firm fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Quest Diagnostics Incorporated, a provider of diagnostic information services. The contract is for "QUEST DIAGNOSTICS DATA" and has a period of performance through March 3, 2025. Quest Diagnostics has previously provided COVID-19 and other infectious disease testing services, as well as reference laboratory testing support, to various federal agencies...
The U.S. Centers for Disease Control and Prevention (CDC) awarded an Indefinite Delivery Indefinite Quantity (IDIQ) contract to Quest Diagnostics Incorporated, a provider of diagnostic information services, for a "Test Surge and Data Sharing" program. The $493,118 contract has a period of performance through September 2025 and is a time and materials type contract. This IDIQ vehicle allows the CDC to procure clinical laboratory testing and analysis services from Quest Diagnostics on an...